癌症中采用细胞疗法的进展:从机械突破到临床前沿,克服障碍
Syed Arman Rabbani1, Mohamed El-Tanani1, Yahia El-Tanani2
1RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
Medical sciences (Basel, Switzerland)
|September 22, 2025
概括
收养细胞疗法 (ACT),包括CAR-T,TIL和TCR治疗,正在改变癌症护理. 目前正在进行的创新旨在提高血液癌症和固体瘤的疗效和安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 采用细胞疗法 (ACT) 利用T淋巴细胞治疗癌症,而化学抗原受体 (CAR) -T细胞在血液癌症中表现出成功.
- 瘤透淋巴细胞 (TIL) 和T细胞受体 (TCR) 工程的T细胞为固体瘤和细胞内点提供了替代策略.
研究的目的:
- 审查ACT的演变和当前状态,包括CAR-T,TIL和TCR疗法.
- 综合与ACT相关的机制,临床结果和挑战.
- 突出提高下一代ACT安全性和有效性的策略.
主要方法:
- 审查关于CAR-T,TIL和TCR疗法的现有文献.
- 对临床试验数据和结果的分析.
- 综合创新的策略,以改善ACT.
主要成果:
- ACT已经显示出显著的希望,但面临着诸如毒性和制造可扩展性等挑战.
- 为了克服这些障碍,正在开发下一代策略,如双抗原向和基因编辑.
- 制造业和计算生物学方面的进步正在为ACT的更广泛应用铺平道路.
结论:
- 包括CAR-T,TIL和TCR在内的ACT正在发展成为各种癌症的强大"活药".
- 未来的方向侧重于减轻毒性,提高疗效,并改善生产,使患者更受益.
- 持续的创新有望为血液和固体瘤提供更安全,更持久和更广泛的细胞疗法.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Bone Marrow Sampling and Transplants
899
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
899
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


